Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA, commonly known as Dräger, is a German family-owned, publicly listed company headquartered in Lübeck, Schleswig-Holstein, Germany. Founded in 1889 by Heinrich Dräger, the company represents a quintessential example of a German "hidden champion"—a global technology leader in its niche that maintains family ownership while accessing public capital markets through listings on the Frankfurt and Hamburg stock exchanges (ticker: DRW3). With a brand heat score of 82/100 in its served markets, Dräger commands extraordinary brand authority among professional users, with its products serving as the "last line of defense" for firefighters, industrial workers, military personnel, and healthcare providers operating in the most hazardous environments on Earth. The company's unique dual-structure governance model combines the strategic patience and commitment of family ownership with the financial resources available through public markets, enabling sustained investment in long-cycle R&D that has produced industry-leading innovations for over 135 years. Dräger operates as a fully integrated developer, designer, and manufacturer, maintaining strict in-house production control over critical components including sensors, valves, electronic control systems, and integrated system assembly to ensure the extreme reliability demanded by life-critical applications.

Core Business

Dräger's business portfolio is organized around two integrated segments: Medical (anaesthesia workstations, ventilators, patient monitoring) and Safety (breathing protection, gas detection, safety solutions), with the safety segment aligning to its core competency as the world's leading provider of active respiratory protection systems. In the respiratory protection category, Dräger's product range spans the complete spectrum from filtering face pieces and half-mask respirators to powered air-purifying respirators (PAPR) and self-contained breathing apparatus (SCBA), with the flagship X-plore® 8000 Series PAPR offering an industry-leading 12-hour battery life and operational temperature range of -30°C to 60°C, enabling use in extreme environmental conditions. The PSS® 7000 and PSS® BG4 SCBA systems represent the gold standard for firefighter and rescue operations, with NFPA 1981 certification and integration capabilities with communication and monitoring systems. In the gas detection segment, the Dräger X-am® 8000 multi-gas detector can identify and monitor over 80 different gases simultaneously, serving industrial hygiene, hazmat response, and confined space entry applications. The company's specialized protection segment encompasses gas-tight chemical protective suits, firefighter thermal exposure suits, heat imaging cameras, and gas detection instrumentation that integrate with respiratory systems to create comprehensive life support units for the most extreme occupational hazards. Unlike competitors offering passive protection equipment, Dräger provides active life support systems that actively supply clean breathing air, representing the highest level of protection complexity and technical integration.

Global Presence

Dräger maintains a global manufacturing and commercial infrastructure centered on its Lübeck headquarters, where the company conducts its most advanced R&D and manufactures its most sophisticated products, preserving the German manufacturing heritage that underpins its quality reputation. The company's European manufacturing footprint extends across multiple highly integrated production facilities that maintain strict vertical integration for critical components, ensuring that sensors, valves, electronic control systems, and assembly operations meet identical quality standards. Dräger's North American operations are anchored by its U.S. subsidiary and manufacturing capabilities that serve the substantial American market for firefighting equipment, industrial safety, and medical devices, with particular strength in serving federal, state, and municipal emergency response agencies. The Asia-Pacific region represents a strategic growth priority, with Dräger expanding its presence in China, Southeast Asia, and India to address growing demand for industrial safety equipment driven by rapid industrialization, increasing occupational safety regulation, and infrastructure development. The company's global service network provides device calibration, preventive maintenance, repair services, and training programs that are essential for customers operating in regulated industries where safety equipment must meet stringent certification and documentation requirements. Dräger's direct sales and service model in key markets ensures that customers receive expert application support, proper equipment selection, and ongoing technical assistance throughout the product lifecycle.

Key Strengths

Dräger's competitive positioning is built upon an exceptional combination of technical leadership, regulatory expertise, customer relationships, and brand authority that creates formidable barriers to entry in its served markets. The company's active respiratory protection technology represents the pinnacle of occupational safety engineering, integrating mechanical, electronic, chemical, and software subsystems into life support systems that must perform flawlessly under the most demanding conditions. This technological complexity creates substantial product development barriers that limit competitive entry, while Dräger's regulatory certification portfolio—including NFPA, ATEX, IECEx, and numerous national standards—requires years of investment and testing to achieve, further protecting its market position. The company's brand equity among professional users is exceptional, with Dräger representing the unquestioned standard for reliability and performance in emergency response and industrial safety applications, translating into strong customer loyalty and premium pricing power. Looking ahead, Dräger is well-positioned to benefit from global trends in workplace safety regulation, increasing investment in emergency response capabilities, and growing demand for life-critical medical equipment, with structural growth drivers supporting sustained demand for its highest-protection products. The company's dual-segment business model provides diversification while allowing focused execution in each market, and its family ownership structure enables patient, long-term investment in innovation that supports continued technology leadership. The company holds a VerityRank Score of 88/100.

Financial Performance 2025

Drägerwerk reported net sales of EUR 3,481.9 million in fiscal 2025, an increase of 3.3% on the EUR 3,370.9 million recorded in 2024, or 5.3% at constant currency. Order intake reached EUR 3,569.4 million, up 5.6%. Gross profit rose 4.1% to EUR 1,574.4 million at a gross margin of 45.2%, and EBIT increased 20.3% to EUR 233.4 million — an EBIT margin of 6.7% against 5.8% the year before. Net income for the year was EUR 140.4 million, up 12.5%, and free cash flow came in at EUR 140.2 million. The equity ratio improved to 51.5% and net financial debt stood at just 0.33 times EBITDA, leaving the group with substantial balance-sheet headroom.

The two divisions moved at different speeds. Medical generated EUR 1,995.6 million, up 5.0%, while Safety generated EUR 1,486.3 million, up 1.0% — 42.7% of group revenue. Safety order intake of EUR 1,522.8 million grew 4.6%, outpacing revenue, while Safety fourth-quarter sales of EUR 465.2 million were up 0.8%. The margin improvement was stronger in Medical than in Safety, which is the central tension in the group's current position: the smaller, more defensible safety franchise is growing more slowly than the hospital business alongside it.

Research and development costs rose 4.5% to EUR 337.6 million, equal to 9.7% of group revenue, with 1,865 people working in development departments at year end. The company employs 16,687 people worldwide and maintains its own sales and service companies in around 50 countries, with development and production sites in 13 countries.